VVOS News and Press, Vivos Therapeutics Inc.

2024-05-15 10:43:10 ET More on Vivos Therapeutics Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Vivos Therapeutics Historical earnings data for Vivos Therapeutics Financial information for Vivos Therap...

Vivos Expanding its Revenue Generating Initiatives As Operating Expenses Decrease 22%, Representing Seven Consecutive Quarters of Year Over Year Improvement Due to Successful Cost Cutting Initiatives Management to Host Conference Call Today at 5:00 pm ET LITTLETON, Colo....

Vivos Therapeutics (NASDAQ: VVOS) is a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (“OSA”) i...

LITTLETON, Colo., May 14, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments ...

Vivos Therapeutics (NASDAQ: VVOS) , a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, is spotlighted in a recent Proactive interview. During the interview, Vivos C...

--News Direct-- Vivos Therapeutics CEO Kirk Huntsman joined Steve Darling from Proactive shared significant news regarding the regulatory approval for Medicare reimbursement of their oral medical devices designed for sleep apnea treatment. Huntsman emphasized the unique design of Vivos's ...

2024-04-09 09:25:02 ET More on Vivos Therapeutics Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Vivos Therapeutics Historical earnings data for Vivos Therapeutics Financial information for Vivos Therap...

2024-04-09 08:43:00 ET DENVER, Colo., Apr 09, 2024 ( 247marketnews.com )- Vivos Therapeutics, Inc. (NASDAQ: VVOS ) reported that its CARE Oral Medical Devices is the first oral appliance for the treatment of all severities of obstructive sleep apnea in adults to receive all required...

LITTLETON, Colo., April 09, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatment...

2024-04-09 06:41:13 ET More on Vivos Therapeutics Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Vivos Therapeutics Historical earnings data for Vivos Therapeutics Financial information for Vivos Therap...